Abstract:Two series of novel 2-arylvinyl-naphtho[2,3-d]imidazol-3-ium iodide derivatives and 2-arylvinyl-naphtho[2,3-d]imidazol-3-ium bromide derivatives were designed and synthesized by the structural combination of YM155 with stilbenoids. All compounds were tested for anti-proliferative activity against PC-3, A375 and HeLa human cancer cell lines. Two of the compounds were selected for further investigation: 12b, which showed potent cytotoxicity against the three tested cell lines with IC50 values in the range of 0.06-0.21 mu M, and 71, which displayed excellent selectivity for PC-3 cells with an IC50 of only 22 nM. Western blot analysis results indicated that both 12b and 71 suppress the expression of Bcl-2 and Survivin proteins, which helps induce apoptosis. As determined by the percent of Annexin V-FITC-positive apoptotic cells, 12b was not only significantly more effective than 71 at a concentration of 100 nM in PC-3 cells but also induced apoptosis in a dose-dependent manner with more potency than 71 at a concentration of 1000 nM in A375 cells. Therefore, compound 12b was chosen for further in-depth studies investigating the mechanism of apoptosis. The results showed that it could activate caspase-3, hydrolyze PARP, and even inactivate ERK. Moreover, 12b arrested A375 cells at S phase in a time dependent and dose-dependent manner, while having a visible effect on microtubule dynamics. In addition, (E)-2-(2-(1H-indol-3-yl)vinyl)-1-benzyl-3-(2-methoxyethyl)-4,9-dioxo-4,9-dihydro-1H-naphtho[2,3-d]imidazol-3-ium bromide (12b) exhibited significant antitumor activity when evaluated in a subcutaneous solid tumor model. Our study reveals that 2-arylvinyl-substituted naphtho[2,3-d]imidazolium scaffolding is a promising new entity for the development of multi-target anticancer drugs. (C) 2017 Published by Elsevier Masson SAS.

Design, Synthesis, and Antitumor Evaluation of Novel Naphthalimide Derivatives

Synthesis and Evaluation of 2-[2-(phenylthiomethyl)-1h-benzo[d] Imidazol-1-yl)acetohydrazide Derivatives As Antitumor Agents

Synthesis and anticancer evaluation of new disulfides incorporating naphthalimide moiety

Synthesis, Antitumor and Antimicrobial Evaluation of Novel 1,3,4-Thiadiazole Derivatives Bearing Disulfide Bond

Synthesis and Antitumor Evaluation of Novel 5-Hydrosulfonyl-1h-benzo[d]imidazol-2(3h)-one Derivatives.

Synthesis and Biological Evaluation of Disulfides Bearing 1,2,4-Triazole Moiety As Antiproliferative Agents

Synthesis and Antitumor Effects of a New Class of 1,2,4-Triazole Derivatives

Synthesis and Antitumor Activities of Disulfide Derivatives Containing 1,3,4-Thiadiazole Moiety

Novel naphthalimide-amino acid conjugates with flexible leucine moiety as side chain: design, synthesis and potential antitumor activity.

Novel Naphthalimide Derivatives As Potential Apoptosis-Inducing Agents: Design, Synthesis and Biological Evaluation.

Synthesis And Anti-Tumor Study Of 3-Aryl-4-Oxo-Thiazolidin-2-Carboxylic Acid Amides

Synthesis and in Vitro Antiproliferative Evaluation of Novel Nonsymmetrical Disulfides Bearing 1,3,4-Oxadiazole Moiety

Synthesis and in vitro antitumor activity evaluation of novel 5-cyano-6-phenyl-2,4-disubstituted-pyrimidine derivatives

Synthesis and Biological Evaluation of Nitrate Derivatives of Thiocolchicine as Potential Anticancer Drugs

Synthesis and Antitumor Evaluation of a Novel Series of Triaminotriazine Derivatives.

Design, Synthesis, Antiproliferative and Antibacterial Evaluation of Quinazolinone Derivatives

Synthesis, Structure-Activity Relationships and Preliminary Antitumor Evaluation of Benzothiazole-2-Thiol Derivatives As Novel Apoptosis Inducers

Synthesis and Antitumor Activity Evaluation of Novel 2-Amino-5-ethylpyrimidine Derivatives

Discovery, Synthesis, and Activity Evaluation of Novel Five-Membered Sulfur-Containing Heterocyclic Nucleosides as Potential Anticancer Agents In Vitro and In Vivo

Synthesis and antitumor activity evaluation of the derivatives of 1,2,4 - triazole -5 - thione bis - schiff base

Synthesis and Biological Evaluation of Novel 2-Arylvinyl-substituted Naphtho[2,3-D]imidazolium Halide Derivatives As Potent Antitumor Agents